A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

Abroad (travel likely)Recruiting

Conditions

CIN - Cervical Intraepithelial Neoplasia · CIN 1 · CIN 2 · HPV · Cervical Cells

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

KGK Science Inc., London, Ontario, Canada
Contact: Study coordinator (Erin Lewis, PhD) · elewis@kgkscience.com · 1-226-242-4551
Contact: Principal Investigator (David Crowley, MD)

Study leads

David Crowley, MD
Principal Investigator
KGK Science Inc.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

CIN 2/3 · HPV Infection · Pre-Cancerous Dysplasia

Abroad (travel likely)RecruitingPHASE2

Fort Myers, United States · Ann Arbor, United States

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

High-risk HPV (Any Strain) · LSIL, Low Grade Squamous Intraepithelial Lesion · ASC-US

Abroad (travel likely)RecruitingPHASE2

Shatin, Hong Kong

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Human Papillomavirus (HPV) · Cervical Intraepithelial Neoplasia · Uterine Cervical Neoplasms

Abroad (travel likely)Recruiting

San Salvador, El Salvador

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

Cervical Cancer · Cervical Cancer Screening · Human Papillomavirus (HPV) Infection

Abroad (travel likely)Recruiting

Zaporizhzhya, Ukraine